logo-loader
LSE:RENE FRA:RQE1

ReNeuron Group PLC

Market:
LSE
Market Cap:
£61.18 m
Price
105.51 GBX
Change
2.94%
52 weeks high
174.29
52 weeks low
69.13

In brief

ReNeuron is a leading, clinical-stage stem cell business.  Its primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.